# A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea And Vomiting in the Bariatric Surgery Population

> **NCT06585540** · PHASE3 · RECRUITING · sponsor: **Benaroya Research Institute** · enrollment: 100 (estimated)

## Conditions studied

- Post Operative Nausea and Vomiting

## Interventions

- **DRUG:** Amisulpride IV Prevention
- **DRUG:** Amisulpride IV Treatment
- **DRUG:** Placebo Preventative
- **DRUG:** Placebo Treatment

## Key facts

- **NCT ID:** NCT06585540
- **Lead sponsor:** Benaroya Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-13
- **Primary completion:** 2025-09
- **Final completion:** 2026-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06585540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06585540, "A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea And Vomiting in the Bariatric Surgery Population". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06585540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*